Stocks and Investing Stocks and Investing
Tue, January 4, 2022
Mon, January 3, 2022

Anupam Rama Maintained (ATRA) at Buy with Increased Target to $675 on, Jan 3rd, 2022


Published on 2024-10-27 19:06:53 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Buy with Increased Target from $650 to $675 on, Jan 3rd, 2022.

Anupam, nor any peers, have made any analyst calls on ATRA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources